Development of targeted gold nanocluster for advanced cancer therapies

Nanomedicines are on the cusp of revolutionising diagnosis and therapy in cancer. Current therapies are mostly ineffective, and better delivery systems are needed to increase the successful clinical translation of drug discoveries. The development of advanced-stimuli-responsive nanomaterials have the potential to be the basis for novel cancer therapies.

Enhanced research experiences